Cargando…
Predictive and prognostic biomarkers of targeted agents and modern immunotherapy in renal cell carcinoma
In the past decade, several agents targeting angiogenesis and signal transduction pathways have replaced the use of cytokines as standard of care treatment for metastatic renal cell carcinoma (RCC) after showing improved clinical benefit and survival. Currently, several novel immunotherapy agents ta...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070260/ https://www.ncbi.nlm.nih.gov/pubmed/27843601 http://dx.doi.org/10.1136/esmoopen-2015-000013 |